Summary
Researchers reviewed eleven studies on Operculina macrocarpa, known as jalapa or purgative potato, a plant traditionally used as a purgative in the Brazilian Northeast. The data indicate that the tuberous root contains resin glycosides and polysaccharides, confirming its rapid cathartic action. However, the research also revealed a narrow therapeutic window and the need for standardization of doses, as empirical use may lead to risks, especially with the substitution by other species of the genus Operculina. Although the plant shows potential for regulated phytotherapeutics, additional clinical trials and rigor in botanical authentication are necessary to ensure the safety and efficacy of its use.
Key points
- The root of Operculina macrocarpa is rich in resin glycosides and polysaccharides, confirming its purgative action.
- The plant presents a narrow therapeutic window, which may increase the risk of adverse effects.
- Empirical use without dose standardization may lead to inadequate substitutions by other species of Operculina.
- Pharmacological data indicate a possible antiplatelet effect, requiring caution in use.
- The research highlights the need for clinical trials and rigorous botanical authentication to ensure safety.
✦ For you
If you are considering using jalapa (Operculina macrocarpa) as a purgative, observe how your body reacts and if there are any side effects. It is important to be attentive to the origin of the plant, as substitutions may occur. Always seek information about the appropriate dosage and, if necessary, consult a qualified healthcare professional for safe guidance.
For practitionersExpand
When considering the prescription of Operculina macrocarpa, evaluate the origin of the plant and the standardization of doses. Be aware of the narrow therapeutic window and the risks associated with empirical use. Rigorous botanical authentication is essential to ensure patient safety. Also consider the possibility of antiplatelet effects when integrating this herb into formulations.